Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Clinical Study to Assess the Benefit of Non-invasive PGT-A, by the Analysis of Spent Blastocyst Media, as a Tool for Embryo Prioritization in Infertile Patients Undergoing Assisted Reproduction.

NCT04000152 is registered in ClinicalTrials.gov with Igenomix as lead sponsor.

NCT NCT04000152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04000152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Clinical Study to Assess the Benefit of Non-invasive PGT-A, by the Analysis of Spent Blastocyst Media, as a Tool for Embryo Prioritization in Infertile Patients Undergoing Assisted Reproduction.
Lead sponsor
Igenomix
Phase
Not applicable
Overall status
Terminated
Start date
June 29, 2020
Completion date
April 18, 2025
Enrollment
296 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

aneuploidy, chromosome abnormality, infertility